Some patients with interstitial lung disease (ILD) have a fibrotic phenotype. Some of these patients respond – at least in the short term – to therapy. In some cases, however, the disease continues to progress despite treatment. What is the appropriate option under which circumstances has been formulated in new guidelines.
This content is machine-translated. Please contact us if you need professional translation services.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Journal Club
Atopic dermatitis and the skin microbiome: new study findings
- AID systems for type 1 diabetes
New real-world data shows: AI makes the difference
- Derma-oncology
Current study results underline the risk of skin cancer
- Vaccines against pneumococci, influenza & RSV
Avoid exacerbations with the vaccination
- Rehospitalization
Analysis of unplanned readmissions to acute care hospitals.
- Cardiorenal syndrome
Cross-talk between heart and kidney
- Suspicion of coronary heart disease
Stress echocardiography, MR heart or computed tomography heart?
- Chronic urticaria